Esophageal Cancer Clinical Trials
CPMC Cancer Services
Oncology / Cancer Clinical Trials Main Page | Adult Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Active Trials
Title: A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery
Description: Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Investigators: NCI - National Cancer Institute
Eligibility: Patients with esophageal cancer
Status: Active and open to enrollment
Contact: Brenda Eng, 415-600-1775,
Email: EngB@cpmcri.org about Study RTOG 0436
- updated April 2012
Back to top
